Jun 10, 2020 / 07:00PM GMT
Nathan Allen Rich – Goldman Sachs Group, Inc., Research Division – Research Analyst
My name is Nathan Rich, and I cover the animal health space here at Goldman. We’re very pleased today to introduce our next session with Elanco and the company’s President and CEO, Jeff Simmons; and Todd Young, the company’s CFO.
We’re going to start the session today with some prepared remarks from Jeff, and then we’ll get into the Q&A.
Before we get started, I’d just like to remind everyone that if anyone would like to ask a question during the course of this session, you can do so either through the webcast or by sending an e-mail to myself at [email protected], and we’ll try to get to your question.
So with that, Jeff and Todd, thanks so much for joining us today.
Jeffrey N. Simmons – Elanco Animal Health Incorporated – President, CEO & Director
Great. Thank you, Nathan. I think given the technology, it will primarily be me, but if we needed to bring Todd in, we could. So let me just open real quick, like just with a brief maybe 1-minute
Source: gurufocus.com
